A Patient Advocate to Facilitate Access and Improve Communication, Care, and Outcomes in Adults with Moderate or Severe Asthma: Rationale, Design, and Methods of a Randomized Controlled Trial
Overview
Authors
Affiliations
Few interventions to improve asthma outcomes have targeted low-income minority adults. Even fewer have focused on the real-world practice where care is delivered. We adapted a patient navigator, here called a Patient Advocate (PA), a term preferred by patients, to facilitate and maintain access to chronic care for adults with moderate or severe asthma and prevalent co-morbidities recruited from clinics serving low-income urban neighborhoods. We describe the planning, design, methodology (informed by patient and provider focus groups), baseline results, and challenges of an ongoing randomized controlled trial of 312 adults of a PA intervention implemented in a variety of practices. The PA coaches, models, and assists participants with preparations for a visit with the asthma clinician; attends the visit with permission of participant and provider; and confirms participants' understanding of what transpired at the visit. The PA facilitates scheduling, obtaining insurance coverage, overcoming patients' unique social and administrative barriers to carrying out medical advice and transfer of information between providers and patients. PA activities are individualized, take account of comorbidities, and are generalizable to other chronic diseases. PAs are recent college graduates interested in health-related careers, research experience, working with patients, and generally have the same race/ethnicity distribution as potential participants. We test whether the PA intervention, compared to usual care, is associated with improved and sustained asthma control and other asthma outcomes (prednisone bursts, ED visits, hospitalizations, quality of life, FEV1) relative to baseline. Mediators and moderators of the PA-asthma outcome relationship are examined along with the intervention's cost-effectiveness.
Holmen H, Flolo T, Torris C, Loyland B, Almendingen K, Bjornnes A Int J Environ Res Public Health. 2024; 21(1).
PMID: 38248501 PMC: 10815593. DOI: 10.3390/ijerph21010036.
Apter A, Bryant-Stephens T, Han X, Park H, Morgan A, Klusaritz H Contemp Clin Trials. 2022; 118:106808.
PMID: 35644376 PMC: 9973549. DOI: 10.1016/j.cct.2022.106808.
Understanding Autonomy in Patients with Moderate to Severe Asthma.
Buckey T, Morales K, Apter A J Allergy Clin Immunol Pract. 2021; 10(2):525-533.
PMID: 34785390 PMC: 8840936. DOI: 10.1016/j.jaip.2021.10.068.
Patient Advocates for Low-Income Adults with Moderate to Severe Asthma: A Randomized Clinical Trial.
Apter A, Perez L, Han X, Ndicu G, Localio A, Park H J Allergy Clin Immunol Pract. 2020; 8(10):3466-3473.e11.
PMID: 32673877 PMC: 7924969. DOI: 10.1016/j.jaip.2020.06.058.
Approaches to the assessment of severe asthma: barriers and strategies.
Majellano E, Clark V, Winter N, Gibson P, McDonald V J Asthma Allergy. 2019; 12:235-251.
PMID: 31692528 PMC: 6712210. DOI: 10.2147/JAA.S178927.